Skip to main content

Global Allergy Immunotherapy Market is estimated at US$2,116.0 million in 2022 and should show a CAGR of 9.3% over the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.

The growing approval of immunotherapy by regulatory authorities is expected to drive the market growth over the forecast period.

For example, in 2014, Stallergenes SA, a healthcare company that manufactures the allergy immunotherapy product, received US Food and Drug Administration approval for ORALAIR(R), for the treatment of rhinitis allergy induced by grass pollen with or without conjunctivitis.

Click here for free sample copy (use corporate email id for higher priority) @ https://www.coherentmarketinsights.com/insight/request-sample/4915

For example, in February 2020, Aimmune Therapeutics, a biopharmaceutical company, received approval from the United States Food and Drug Administration for its oral peanut protein immunotherapy AR101 (Palforzia) for the indication of food allergy. .

Patients with multiple sensitivities may require a combination of allergens. The concentration of allergens in the mixtures will decrease as more patients are exposed to them. The patient will also benefit from immunotherapy to prevent the onset of asthma in patients with hay fever. It is important to consult a qualified allergist to determine the appropriate dosage.

Global Allergy Immunotherapy Market – Impact of COVID-19 (Demand and Supply Chain Analysis)

The COVID-19 pandemic and lockdowns in various countries around the world have had an impact on the financial situation of companies in all sectors. The private healthcare sector is one such sector that has been heavily impacted by the pandemic.

Additionally, the coronavirus pandemic has negatively impacted the supply of raw materials needed to produce health supplements, including brain health supplements, across the globe.

Furthermore, the COVID-19 pandemic has affected the economy in three main ways; 1) directly affecting production and demand; 2) by creating disturbances in the distribution circuits; and 3) through its financial impact on businesses and financial markets.

Various manufacturers are facing problems such as labor shortage and transportation of raw materials, which has affected the production of immunotherapy. Most of the vehicles used to transport these products are stuck at state lines or country borders.

Factors such as increasing strategic collaborations and partnerships by key players to expand their presence are expected to boost the growth of the global allergy immunotherapy market.

For more information or query or customization before buying, visit at – https://www.coherentmarketinsights.com/insight/talk-to-analyst/4915

For example, in October 2021, Aptar Pharma, a provider of drug delivery systems, services and active ingredient solutions, entered into a partnership with Stallergenes Greer, a healthcare company specializing in allergen immunotherapy, for the development of a new connected drug delivery device and mobile companion. application.

Key points of the Global Allergy Immunotherapy Market:

  • The Global allergy immunotherapy market should show a CAGR of 3%over the forecast period, due to the increasing prevalence of asthma. For example, according to the Centers for Disease Control and Prevention (CDC), approximately 27 million people in the United States suffered from asthma in 2016. Additionally, it is the most common chronic disease among American children, where one in every 12 children has asthma.
  • Among the treatment types, the subcutaneous immunotherapy segment is expected to account for the largest market share in 2022, owing to the most commonly used and effective form of allergy immunotherapy, it is the only allergy immunotherapy treatment that actually alters a patient’s immune system.
  • Key players operating in the global Allergy Immunotherapy market include Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Allergopharma, HAL Allergy Group, Aimmune Therapeutics, DBV Technologies, Leti Pharma and Jubilant HollisterStier.

Up to 30% off various types of buy-it-now licenses @ https://www.coherentmarketinsights.com/promo/buynow/4915

Contents

  1. Research objectives and hypotheses
    • Research objectives
    • Hypotheses
    • Abbreviations
  2. Market scope
    • Description of the report
      • Market definition and scope
    • Summary
      • Market extract, by type of treatment
      • Market Extract, by Allergy Type
      • Market extract, by distribution channel
      • Market extract, by region
    • Consistent Opportunity Map (COM)
  3. Market dynamics, regulation and trend analysis
    • Drivers
    • Constraints
    • Market opportunities
    • Impact analysis
    • Highlights
    • Regulatory scenario
    • Product Launch/Approval
    • Epidemiology
    • PEST analysis
    • Acquisition and collaboration scenario
  4. Global Allergy Immunotherapy Market – Impact of the Coronavirus (COVID-19) Pandemic
    • Economic impact
    • Impact of COVID 19 on Supply Chain Analytics
  5. Global Allergy Immunotherapy Market, by Treatment Type, 2017-2030, (USD Million)
    • Introduction
      • Market share analysis, 2022 and 2030 (%)
      • Annual Growth Analysis, 2018 – 2030
      • Industry trends
    • Subcutaneous immunotherapy (SCIT)
      • Introduction
      • Market Size & Forecast & Annual Growth, 2017-2030, (USD Million)
    • Sublingual immunotherapy (SLIT)
      • Introduction
      • Market Size & Forecast & Annual Growth, 2017-2030, (USD Million)
  6. Global Allergy Immunotherapy Market, by Allergy Type, 2017-2030, (USD Million)
    • Introduction
      • Market share analysis, 2022 and 2030 (%)
      • Annual Growth Analysis, 2018 – 2030
      • Industry trends
    • Allergic rhinitis
      • Introduction
      • Market Size & Forecast & Annual Growth, 2017-2030, (USD Million)
    • allergic asthma
      • Introduction
      • Market Size & Forecast & Annual Growth, 2017-2030, (USD Million)
    • Food allergy
      • Introduction
      • Market Size & Forecast & Annual Growth, 2017-2030, (USD Million)
    • Venom allergy
      • Introduction
      • Market Size & Forecast & Annual Growth, 2017-2030, (USD Million)
    • Others
      • Introduction
      • Market Size & Forecast & Annual Growth, 2017-2030, (USD Million)
  7. Global allergy immunotherapy market, by distribution channel, 2017-2030, (USD Million)
    • Introduction
      • Market share analysis, 2022 and 2030 (%)
      • Annual Growth Analysis, 2018 – 2030
      • Industry trends
    • Hospitals Pharmacies
      • Introduction
      • Market Size & Forecast & Annual Growth, 2017-2030, (USD Million)
    • Retail pharmacies
      • Introduction
      • Market Size & Forecast & Annual Growth, 2017-2030, (USD Million)
    • Online pharmacies
      • Introduction
      • Market Size & Forecast & Annual Growth, 2017-2030, (USD Million)

See press release: https://www.coherentmarketinsights.com/press-release/allergy-immunotherapy-market-4188

About Us:

Coherent Market Insights is a global market intelligence and advisory organization that provides syndicated research reports, custom research reports and advisory services. We are known for our actionable insights and genuine reports in various fields, including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually any field and an exhaustive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leadership role in providing insight in various post-COVID-19 industries and to continuing to deliver measurable and sustainable results to our clients.

Contact us:

Mr Shah
Consistent market information
1001 4th Ave, #3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837